Showing results (131-140 of 180) with videos related to

Sort By:
Pageof 18
Plos Neglected Tropical Diseases|August 8, 2014
Visceral leishmaniasis and HIV co-infection in Bihar, India: long-term effectiveness and treatment outcomes with liposomal amphotericin B (AmBisome)Sakib Burza, Raman Mahajan, Prabhat K Sinha, et al.
Journal of Clinical Microbiology|August 28, 2020
Evaluation of Cysteine Protease C of Leishmania donovani in Comparison with Glycoprotein 63 and Elongation Factor 1α for Diagnosis of Human Visceral Leishmaniasis and for Posttreatment Follow-Up ResponseNicky Didwania, Sarfaraz Ahmad Ejazi, Rudra Chhajer, et al.
Indian Journal of Dermatology, Venereology and Leprology|February 13, 2021
A randomized, open-label study to evaluate the efficacy and safety of liposomal amphotericin B (AmBisome) versus miltefosine in patients with post-kala-azar dermal leishmaniasisKrishna Pandey, Biplab Pal, Niyamat Ali Siddiqui, et al.
Tropical Medicine & International Health : TM & IH|November 10, 2012
Oral miltefosine for Indian post-kala-azar dermal leishmaniasis: a randomised trialShyam Sundar, Prabat Sinha, T K Jha, et al.
Journal of Clinical Microbiology|January 27, 2012
Post-kala-azar dermal leishmaniasis in a patient treated with injectable paromomycin for visceral leishmaniasis in IndiaKrishna Pandey, V N R Das, Dharmendra Singh, et al.
Plos Neglected Tropical Diseases|August 24, 2021
Improved kala-azar case management through implementation of health facility-based sentinel sites surveillance system in Bihar, IndiaVidya Nand Rabi Das, Niyamat Ali Siddiqui, Gouri Sankar Bhunia, et al.
Journal of Cellular Biochemistry|June 7, 2017
Mining the Proteome of Leishmania donovani for the Development of Novel MHC Class I Restricted Epitope for the Control of Visceral LeishmaniasisManas R Dikhit, , Akhilesh Kumar, et al.
Antimicrobial Agents and Chemotherapy|December 7, 2007
Inhibition of ABC transporters abolishes antimony resistance in Leishmania InfectionJayati Mookerjee Basu, Ananda Mookerjee, Rajdeep Banerjee, et al.
Iranian Journal of Parasitology|January 31, 2019
Identification of Clinical Immunological Determinants in Asymptomatic VL and Post Kala-azar Dermal Leishmaniasis PatientsAshish Kumar Singh, Vidya Nand Rabi DAS, Ajay Amit, et al.
Plos Neglected Tropical Diseases|June 20, 2020
Conversion of asymptomatic infection to symptomatic visceral leishmaniasis: A study of possible immunological markersVidya Nand Rabi Das, Sanjiva Bimal, Niyamat Ali Siddiqui, et al.
Pageof 18